GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD.

Otros idiomas Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Acciones

874 CNE100000387

Farmacéuticos

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 09:08:17 13/12/2024			Varia. Cinco días.	Varia. 1 de enero.
18,22 ^HKD	-0,76 %		+0,44 %	-16,23 %

28/11	La unidad de Baiyunshan Pharma obtiene el visto bueno para realizar cambios en los comprimidos de Selaginella Jiangnanensis	MT
28/11	Baiyunshan Pharma obtiene el visto bueno para comercializar un fármaco antitumoral	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Baiyunshan Pharma's Unit Gets Nod to Make Changes to Selaginella Jiangnanensis Tablets	28/11
Baiyunshan Pharma Gets Nod to Market Anti-Tumor Drug	28/11
Guangzhou Baiyunshan Pharmaceutical Unit Gets Approval for Antibiotic in China	26/11
China Approves Baiyunshan Pharma Unit's Supplementary Application for Traditional Chinese Drug	22/11
Guangzhou Baiyunshan Pharmaceutical Unit Gets Additions to Drug Production License	19/11
Guangzhou Baiyunshan Pharmaceutical's Factory Passes Generic Drug Consistency Evaluation for Two Antibiotics	04/11
Baiyunshan Pharmaceutical's Q3 Profit Plunges 38%	25/10
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2024	18/10
Guangzhou Baiyunshan Pharmaceutical Branch Gets Supplementary Drug Application for Antibiotic	16/10
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Approves Interim Dividend for the Six Months Ended 30 June 2024, Payable November 15, 2024	27/09
Guangzhou Baiyunshan Pharmaceutical Gets License to Expand Unit's Drug Production License	13/09
Baiyunshan Pharma Gets China Supplemental Drug Nod for Nitroglycerin Injection for Heart Problems	10/09
Baiyunshan Pharmaceutical's Executive Director Resigns Amid Ongoing Investigation	03/09
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Resignation of Mr. Zhang Chunbo as Director	01/09
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Proposes Interim Dividend for the Six Months Ended 30 June 2024, Payable November 15, 2024	30/08
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Half Year Ended June 30, 2024	30/08
TravelSky Technology Limited Announces Resignation of Yang Jun as Shareholder Representative Supervisor	28/08
Guangzhou Baiyunshan Secures Marketing Authorization for Compound Acetaminophen Granules	19/08
Guangzhou Baiyunshan Pharmaceutical Passes Quality, Consistency Evaluation for Antibiotic	13/08
Baiyunshan Pharmaceutical to Build Guangzhou Factory For 3.2 Billion Yuan	05/08
Guangzhou Baiyunshan Pharmaceutical's Chairperson Resigns; Shares Down 3%	23/07
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Board Changes	22/07
Guangzhou Baiyunshan Pharmaceutical Secures Drug Registration for Erectile Dysfunction Tablets	27/06
Baiyunshan Pharmaceutical's Unit Gets Regulatory Nod to Add Specification for Dopamine Hydrochloride Injection	19/06
Baiyunshan Pharmaceutical's Unit Gets Nod from Macao's Drug Regulator to Import, Export Pearl Powder	17/06

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Acciones

874

CNE100000387

Farmacéuticos

Otros idiomas

Filtros